Purchase Order 75N98026P00678

This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) for a "Service Agreement for Zoe". The contract has a ceiling value of $19,096.00 and a period of performance through May 30, 2026. It was awarded on May 31, 2024 and was not set aside for any specific business category. Emulate is a biotechnology...

The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $171,400 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the expansion of their ZOE microphysiological system. The place of performance will be Emulate's facilities in Research Triangle Park, North Carolina, and work is to be completed between September 14, 2023 and October 13, 2023. The associated sole source solicitation sought...

This firm fixed price purchase order for $144,800 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Emulate Inc., doing business as Emulate, for the delivery of four ZOE culture module updates from Configuration 1 to Configuration 2. No set-aside designation was used for this procurement. Place of performance will be Emulate's facilities in Boston, Massachusetts. Emulate is a for-profit...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated...

This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $217,700.00 firm-fixed-price purchase order contract to Emulate Inc., doing business as Emulate, a small business organization. The contract is for upgrades to the existing Zoe Culture Module Systems. This contract supports NIAID's initiatives in areas such as personalized medicine, biosurveillance, infectious disease research, and alternatives to animal testing. Emulate Inc. has provided a wide range of...

This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...

This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...

The Food and Drug Administration awarded a Total Small Business set-aside purchase order to Emulate Inc. on June 28, 2022, for the procurement of organ-on-chip microphysiological systems. The contract specifies delivery of two (2) Human Emulation System Zoe Culture Module 2 units and two (2) Orb Hub Modules, with a firm fixed price ceiling value of $218.1K and an ultimate completion date of August 27, 2023. Performance will be conducted in Laurel, Maryland. Emulate Inc., headquartered in Boston,...